Detalles de la búsqueda
1.
Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial.
Support Care Cancer
; 32(1): 34, 2023 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38103088
2.
Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab.
BMC Cancer
; 20(1): 783, 2020 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32819305
3.
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
N Engl J Med
; 375(18): 1738-1748, 2016 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717303
4.
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE.
J Clin Oncol
; 39(1): 79-89, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822287
5.
MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2--Advanced Breast Cancer.
Clin Cancer Res
; 27(21): 5801-5809, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376533
6.
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial.
JAMA Oncol
; 6(1): 116-124, 2020 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563959
7.
An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer.
Lung Cancer
; 136: 74-79, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446228
8.
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE.
J Clin Oncol
; 36(8): 741-748, 2018 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29244528
9.
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.
J Clin Oncol
; 35(25): 2875-2884, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28580882
10.
Eniluracil plus 5-fluorouracil and leucovorin: treatment for metastatic breast cancer patients in whom capecitabine treatment rapidly failed.
Clin Breast Cancer
; 14(1): 26-30, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24183612
11.
Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer.
Lung Cancer
; 86(1): 67-72, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25154982
12.
A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).
J Thorac Oncol
; 9(6): 848-55, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24807156
13.
Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: the RESPECT trial.
Clin Cancer Res
; 19(9): 2541-50, 2013 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23532888
Resultados
1 -
13
de 13
1
Próxima >
>>